CYPROHEPTADINE HYDROCHLORIDE

CYPROHEPTADINE HYDROCHLORIDE was reported 4514 times

CYPROHEPTADINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TORUS FRACTURE 37 0.5211
1 ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY 4 0.5000
2 CYSTIC FIBROSIS GASTROINTESTINAL DISEASE 3 0.1200
3 PNEUMONIA SALMONELLA 4 0.0851
4 ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION 4 0.0556
5 ECHOPRAXIA 3 0.0462
6 MEDULLOBLASTOMA 5 0.0336
7 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 27 0.0302
8 SYMPTOM MASKED 19 0.0261
9 GASTRIC HYPOMOTILITY 7 0.0228
10 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 117 0.0215
11 OBSESSIVE-COMPULSIVE SYMPTOM 7 0.0190
12 OESOPHAGEAL SPASM 34 0.0184
13 ASTROCYTOMA, LOW GRADE 3 0.0176
14 ACUTE MYOPIA 3 0.0165
15 OBSTRUCTIVE SLEEP APNOEA SYNDROME 23 0.0158
16 INJECTION SITE PLAQUE 3 0.0143
17 FEEDING TUBE USER 5 0.0137
18 CARCINOID CRISIS 3 0.0133
19 BUTTERFLY RASH 13 0.0128
20 JUVENILE IDIOPATHIC ARTHRITIS 31 0.0127
21 APALLIC SYNDROME 9 0.0124
22 CYSTIC FIBROSIS 68 0.0123
23 HALLUCINATION, TACTILE 8 0.0120
24 LOWER RESPIRATORY TRACT INFECTION FUNGAL 4 0.0103
25 SEROTONIN SYNDROME 192 0.0100
26 INFECTIVE EXACERBATION OF BRONCHIECTASIS 3 0.0098
27 CENTRAL OBESITY 7 0.0095
28 CLONUS 24 0.0088
29 PULMONARY FUNCTION TEST DECREASED 37 0.0084
30 OESOPHAGEAL PAIN 33 0.0083
31 GROWTH RETARDATION 24 0.0081
32 NECROTISING OESOPHAGITIS 4 0.0080
33 ADHESIVE TAPE USE 3 0.0078
34 GROWTH HORMONE DEFICIENCY 3 0.0076
35 BONE DEMINERALISATION 8 0.0076
36 PUPIL FIXED 13 0.0075
37 NEUROGENIC SHOCK 4 0.0074
38 GLUCOCORTICOID DEFICIENCY 3 0.0071
39 RHINOVIRUS INFECTION 26 0.0067
40 LIMB ASYMMETRY 5 0.0065
41 JOINT DESTRUCTION 10 0.0064
42 HYPERAMMONAEMIC ENCEPHALOPATHY 11 0.0063
43 BODY HEIGHT INCREASED 3 0.0061
44 CHRONIC SINUSITIS 23 0.0061
45 SEIZURE CLUSTER 5 0.0060
46 DISTURBANCE IN SOCIAL BEHAVIOUR 14 0.0059
47 HYPOPERFUSION 6 0.0057
48 INFUSION SITE DISCHARGE 10 0.0057
49 VASCULAR DEVICE INFECTION 24 0.0053
50 GASTROINTESTINAL SURGERY 4 0.0052
51 DIARRHOEA INFECTIOUS 4 0.0051
52 CROUP INFECTIOUS 4 0.0051
53 BEZOAR 7 0.0051
54 HYPERREFLEXIA 17 0.0049
55 NASAL POLYPS 24 0.0049
56 DIAPHRAGMATIC HERNIA 3 0.0048
57 LYMPHOEDEMA 33 0.0048
58 SYSTOLIC DYSFUNCTION 5 0.0047
59 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
60 ENTEROVIRUS INFECTION 4 0.0046
61 DRUG CLEARANCE DECREASED 6 0.0046
62 GASTROSTOMY 7 0.0045
63 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 5 0.0045
64 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 6 0.0044
65 IMMOBILE 19 0.0043
66 MAST CELL ACTIVATION SYNDROME 6 0.0043
67 SLEEP-RELATED EATING DISORDER 4 0.0043
68 INFUSION SITE BRUISING 9 0.0042
69 CLONIC CONVULSION 3 0.0041
70 MASTOIDITIS 4 0.0041
71 POSTICTAL STATE 4 0.0038
72 COGWHEEL RIGIDITY 4 0.0038
73 REGURGITATION 13 0.0038
74 SMALL INTESTINAL STENOSIS 4 0.0038
75 OBSESSIVE-COMPULSIVE DISORDER 30 0.0037
76 REBOUND ACID HYPERSECRETION 11 0.0036
77 QUADRIPARESIS 6 0.0036
78 BRONCHIAL OBSTRUCTION 5 0.0036
79 GLUTEN SENSITIVITY 5 0.0035
80 INFUSION SITE PRURITUS 11 0.0035
81 HYPOTHALAMO-PITUITARY DISORDER 5 0.0034
82 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
83 BLOOD ALBUMIN INCREASED 3 0.0034
84 INFUSION SITE HAEMORRHAGE 11 0.0033
85 ATRIAL TACHYCARDIA 7 0.0033
86 HEART TRANSPLANT 3 0.0033
87 HAEMATOCRIT ABNORMAL 4 0.0033
88 HYPERPARATHYROIDISM SECONDARY 8 0.0032
89 INFUSION SITE NODULE 3 0.0031
90 INFUSION SITE REACTION 9 0.0030
91 TONIC CONVULSION 4 0.0028
92 INFUSION SITE MASS 3 0.0028
93 FAT TISSUE INCREASED 4 0.0028
94 PARAINFLUENZAE VIRUS INFECTION 4 0.0026
95 MYOGLOBIN BLOOD INCREASED 4 0.0026
96 PNEUMONIA PSEUDOMONAL 4 0.0026
97 HYPERAMMONAEMIA 13 0.0026
98 NEPHROGENIC ANAEMIA 12 0.0026
99 ELECTROCARDIOGRAM T WAVE ABNORMAL 4 0.0026
100 PYELONEPHRITIS ACUTE 5 0.0025
101 SLEEP APNOEA SYNDROME 48 0.0025
102 ANTICHOLINERGIC SYNDROME 4 0.0025
103 WEIGHT ABNORMAL 6 0.0025
104 STARING 6 0.0025
105 SLOW SPEECH 6 0.0025
106 OTITIS MEDIA 8 0.0024
107 ILLUSION 4 0.0024
108 EDUCATIONAL PROBLEM 4 0.0024
109 INFUSION SITE SWELLING 15 0.0024
110 HYPERTHERMIA 18 0.0024
111 ANGLE CLOSURE GLAUCOMA 6 0.0023
112 SPUTUM INCREASED 5 0.0023
113 OTORRHOEA 4 0.0023
114 HAEMODYNAMIC INSTABILITY 17 0.0022
115 BEHAVIOUR DISORDER 12 0.0022
116 NASAL OEDEMA 4 0.0022
117 CARBON DIOXIDE INCREASED 3 0.0022
118 BODY TEMPERATURE ABNORMAL 4 0.0022
119 EOSINOPHILIC OESOPHAGITIS 6 0.0022
120 OTOTOXICITY 4 0.0022
121 MALNUTRITION 24 0.0021
122 PRE-EXISTING CONDITION IMPROVED 13 0.0021
123 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
124 END STAGE RENAL DISEASE 37 0.0020
125 DRUG DELIVERY SYSTEM ISSUE 4 0.0020
126 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
127 BLOOD IMMUNOGLOBULIN G DECREASED 5 0.0020
128 GASTROINTESTINAL TUBE INSERTION 5 0.0020
129 INJECTION SITE PARAESTHESIA 3 0.0020
130 INFUSION SITE PAIN 25 0.0019
131 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 5 0.0019
132 PULSELESS ELECTRICAL ACTIVITY 8 0.0019
133 PSEUDOMONAS INFECTION 16 0.0019
134 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
135 INTESTINAL ISCHAEMIA 10 0.0018
136 FOOD AVERSION 3 0.0018
137 GAZE PALSY 3 0.0018
138 RESPIRATORY SYMPTOM 5 0.0018
139 PHARYNGITIS STREPTOCOCCAL 19 0.0018
140 DROOLING 12 0.0017
141 PERIORBITAL OEDEMA 9 0.0017
142 LUNG TRANSPLANT 6 0.0017
143 MENTAL STATUS CHANGES 47 0.0017
144 FIBROMYALGIA 41 0.0017
145 MYOPIA 4 0.0017
146 SINUS OPERATION 4 0.0017
147 DISORGANISED SPEECH 3 0.0016
148 STREPTOCOCCAL INFECTION 9 0.0016
149 PNEUMONIA ASPIRATION 40 0.0016
150 PERIORBITAL SWELLING 9 0.0016
151 BLOOD BICARBONATE DECREASED 3 0.0016
152 VENTRICULAR HYPOKINESIA 5 0.0016
153 INFUSION SITE ERYTHEMA 13 0.0015
154 MULTIPLE ALLERGIES 12 0.0015
155 ECONOMIC PROBLEM 23 0.0015
156 APPETITE DISORDER 10 0.0015
157 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
158 MUSCLE RIGIDITY 18 0.0015
159 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
160 MIOSIS 12 0.0015
161 ANHEDONIA 39 0.0015
162 SEDATION 38 0.0014
163 INTRACRANIAL PRESSURE INCREASED 8 0.0014
164 NEUROLEPTIC MALIGNANT SYNDROME 17 0.0014
165 BUNDLE BRANCH BLOCK LEFT 6 0.0014
166 PERSONALITY CHANGE 13 0.0014
167 HYPERTONIA 8 0.0014
168 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 10 0.0014
169 PYODERMA GANGRENOSUM 5 0.0014
170 HORDEOLUM 6 0.0014
171 CEREBELLAR SYNDROME 3 0.0014
172 FEMORAL NECK FRACTURE 7 0.0014
173 AGITATION 100 0.0014
174 MOOD SWINGS 43 0.0013
175 SINUS TACHYCARDIA 19 0.0013
176 BLOOD CULTURE POSITIVE 4 0.0013
177 METABOLIC ENCEPHALOPATHY 4 0.0013
178 BLOOD LACTIC ACID INCREASED 7 0.0013
179 CENTRAL VENOUS CATHETERISATION 4 0.0013
180 MYDRIASIS 17 0.0013
181 DISTRIBUTIVE SHOCK 3 0.0013
182 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
183 VIRAL INFECTION 43 0.0013
184 EAR INFECTION 34 0.0013
185 PNEUMONIA FUNGAL 5 0.0013
186 RESTLESSNESS 46 0.0013
187 GASTROINTESTINAL OBSTRUCTION 3 0.0012
188 LIQUID PRODUCT PHYSICAL ISSUE 9 0.0012
189 LUPUS-LIKE SYNDROME 11 0.0012
190 SOCIAL AVOIDANT BEHAVIOUR 7 0.0012
191 HYPERNATRAEMIA 6 0.0012
192 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
193 PNEUMOTHORAX 19 0.0012
194 POST-TRAUMATIC STRESS DISORDER 8 0.0012
195 CYSTITIS 38 0.0012
196 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 20 0.0012
197 IMPAIRED GASTRIC EMPTYING 16 0.0012
198 CANCER PAIN 3 0.0012
199 ELECTROCARDIOGRAM QT PROLONGED 42 0.0012
200 ATRIOVENTRICULAR BLOCK 9 0.0012
201 CHRONIC KIDNEY DISEASE 88 0.0012
202 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7 0.0011
203 IRRITABILITY 69 0.0011
204 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
205 SCOLIOSIS 7 0.0011
206 RESPIRATORY RATE INCREASED 10 0.0011
207 BONE DENSITY DECREASED 35 0.0011
208 CARDIOGENIC SHOCK 16 0.0011
209 MIGRAINE 105 0.0011
210 SCREAMING 7 0.0011
211 MYOCLONUS 13 0.0011
212 AUTISM SPECTRUM DISORDER 6 0.0011
213 ISCHAEMIA 5 0.0011
214 GENERALISED TONIC-CLONIC SEIZURE 18 0.0011
215 FEEDING DISORDER 22 0.0011
216 PRODUCT DISTRIBUTION ISSUE 10 0.0011
217 INTENTIONAL OVERDOSE 69 0.0011
218 ENDOTRACHEAL INTUBATION 3 0.0011
219 PRODUCT PREPARATION ISSUE 7 0.0011
220 STATUS EPILEPTICUS 12 0.0011
221 SNORING 4 0.0011
222 PULSE ABSENT 5 0.0011
223 IMPAIRED QUALITY OF LIFE 15 0.0010
224 HYPERTONIC BLADDER 3 0.0010
225 ADENOVIRUS INFECTION 3 0.0010
226 HYPOALBUMINAEMIA 8 0.0010
227 SPINAL CORD COMPRESSION 4 0.0010
228 MOOD ALTERED 28 0.0010
229 PSYCHOMOTOR HYPERACTIVITY 17 0.0010
230 WITHDRAWAL SYNDROME 43 0.0010
231 RESPIRATION ABNORMAL 7 0.0010
232 BREATH SOUNDS ABNORMAL 5 0.0010
233 GASTROINTESTINAL INFECTION 9 0.0010
234 GASTROENTERITIS VIRAL 18 0.0010
235 CRANIOCEREBRAL INJURY 3 0.0010
236 PNEUMONIA BACTERIAL 9 0.0010
237 DELIRIUM 34 0.0010
238 AGGRESSION 49 0.0010
239 IRON DEFICIENCY ANAEMIA 9 0.0010
240 SUICIDAL BEHAVIOUR 4 0.0010
241 TINNITUS 44 0.0010
242 STOMATITIS 58 0.0010
243 WEIGHT FLUCTUATION 10 0.0010
244 PARTIAL SEIZURES 5 0.0010
245 HYPOCALCAEMIA 18 0.0010
246 ATTENTION DEFICIT HYPERACTIVITY DISORDER 4 0.0009
247 NYSTAGMUS 5 0.0009
248 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
249 NASAL CONGESTION 55 0.0009
250 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
251 HYDROCEPHALUS 5 0.0009
252 TIC 5 0.0009
253 ACIDOSIS 7 0.0009
254 INSURANCE ISSUE 14 0.0009
255 SOMNAMBULISM 6 0.0009
256 FAECALOMA 5 0.0009
257 HAEMORRHAGIC ANAEMIA 4 0.0009
258 NECROSIS 5 0.0009
259 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 49 0.0009
260 BRONCHITIS 66 0.0009
261 BRONCHIECTASIS 6 0.0009
262 RHABDOMYOLYSIS 37 0.0009
263 PAPILLOEDEMA 4 0.0009
264 EYE INFECTION 10 0.0009
265 INITIAL INSOMNIA 9 0.0009
266 HALLUCINATION 66 0.0009
267 AUTOIMMUNE HAEMOLYTIC ANAEMIA 3 0.0009
268 NEUROLOGICAL SYMPTOM 5 0.0009
269 HEPATIC FIBROSIS 3 0.0009
270 FUNGAL INFECTION 29 0.0009
271 HYPOPNOEA 3 0.0009
272 RESPIRATORY FAILURE 63 0.0009
273 SEIZURE 99 0.0009
274 NEPHROPATHY 8 0.0009
275 VAGINAL INFECTION 4 0.0008
276 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
277 BLOOD IRON DECREASED 10 0.0008
278 CONJUNCTIVAL HYPERAEMIA 3 0.0008
279 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
280 HEREDITARY ANGIOEDEMA 9 0.0008
281 SYMPTOM RECURRENCE 5 0.0008
282 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
283 HYPOPHAGIA 21 0.0008
284 INTENTIONAL UNDERDOSE 6 0.0008
285 INFLAMMATORY BOWEL DISEASE 8 0.0008
286 MUSCLE SPASTICITY 10 0.0008
287 CARDIAC MURMUR 7 0.0008
288 SINUS DISORDER 16 0.0008
289 CARDIAC DYSFUNCTION 3 0.0008
290 DEVICE MECHANICAL ISSUE 11 0.0008
291 SINUSITIS 82 0.0008
292 CRYING 29 0.0008
293 HEPATIC NECROSIS 3 0.0008
294 APHONIA 11 0.0008
295 GASTRIC INFECTION 3 0.0008
296 PETIT MAL EPILEPSY 4 0.0008
297 ENTERITIS 5 0.0008
298 SEASONAL ALLERGY 11 0.0008
299 DECREASED APPETITE 180 0.0008
300 VASCULITIS 9 0.0008
301 FLUID RETENTION 39 0.0008
302 HYPOXIA 27 0.0008
303 APLASTIC ANAEMIA 4 0.0008
304 CATATONIA 4 0.0008
305 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
306 TRICUSPID VALVE INCOMPETENCE 6 0.0008
307 HYPERPHAGIA 3 0.0008
308 BACTERIAL INFECTION 14 0.0007
309 MIDDLE INSOMNIA 14 0.0007
310 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
311 RHINITIS 6 0.0007
312 ENURESIS 3 0.0007
313 HOSPITALISATION 113 0.0007
314 RESPIRATORY TRACT INFECTION 19 0.0007
315 OSTEOPOROSIS 30 0.0007
316 ACUTE RESPIRATORY FAILURE 14 0.0007
317 OSTEOPENIA 11 0.0007
318 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
319 HAEMOPTYSIS 20 0.0007
320 LETHARGY 41 0.0007
321 DRUG INTERACTION 113 0.0007
322 THERAPY CHANGE 7 0.0007
323 SUICIDE ATTEMPT 43 0.0007
324 REBOUND EFFECT 8 0.0007
325 RETCHING 15 0.0007
326 POOR QUALITY DEVICE USED 7 0.0007
327 HYPERSOMNIA 20 0.0007
328 EXERCISE TOLERANCE DECREASED 4 0.0007
329 HYPERVENTILATION 4 0.0007
330 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
331 RALES 4 0.0007
332 INCREASED APPETITE 13 0.0007
333 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
334 HYPOPHOSPHATAEMIA 5 0.0007
335 ATAXIA 8 0.0007
336 SINUS HEADACHE 4 0.0007
337 RHINORRHOEA 43 0.0007
338 ANXIETY 189 0.0007
339 CONTRAINDICATED PRODUCT ADMINISTERED 20 0.0007
340 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
341 HAEMOGLOBIN INCREASED 3 0.0007
342 ABNORMAL BEHAVIOUR 26 0.0007
343 TACHYCARDIA 58 0.0007
344 SLEEP DISORDER 46 0.0007
345 DECREASED ACTIVITY 7 0.0006
346 EMOTIONAL DISORDER 20 0.0006
347 ABDOMINAL PAIN 150 0.0006
348 LUNG INFECTION 10 0.0006
349 INFUSION SITE EXTRAVASATION 4 0.0006
350 DEVICE INFORMATION OUTPUT ISSUE 5 0.0006
351 ACUTE KIDNEY INJURY 98 0.0006
352 BODY TEMPERATURE INCREASED 13 0.0006
353 CYANOSIS 10 0.0006
354 WEIGHT DECREASED 177 0.0006
355 PNEUMONIA 205 0.0006
356 DENTAL CARIES 7 0.0006
357 GASTRIC ULCER 12 0.0006
358 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 30 0.0006
359 ATELECTASIS 6 0.0006
360 COMPLICATION ASSOCIATED WITH DEVICE 9 0.0006
361 THROMBOTIC MICROANGIOPATHY 6 0.0006
362 PHARYNGEAL SWELLING 6 0.0006
363 INFECTION 88 0.0006
364 HYPERVOLAEMIA 3 0.0006
365 HAIR DISORDER 5 0.0006
366 INFLAMMATORY MARKER INCREASED 3 0.0006
367 RESTLESS LEGS SYNDROME 11 0.0006
368 ABDOMINAL TENDERNESS 3 0.0006
369 FLUID INTAKE REDUCED 3 0.0006
370 MENINGITIS 4 0.0006
371 CONJUNCTIVITIS 11 0.0006
372 SINUS CONGESTION 8 0.0006
373 DRUG LEVEL DECREASED 6 0.0006
374 TACHYPNOEA 8 0.0006
375 AKATHISIA 8 0.0006
376 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 3 0.0006
377 URTICARIA 98 0.0006
378 VITAMIN D DECREASED 5 0.0006
379 LIVER FUNCTION TEST ABNORMAL 17 0.0006
380 UNRESPONSIVE TO STIMULI 15 0.0006
381 THERAPY NON-RESPONDER 26 0.0006
382 FAILURE TO THRIVE 3 0.0006
383 EYE DISCHARGE 6 0.0006
384 DEHYDRATION 77 0.0006
385 SPINAL OSTEOARTHRITIS 5 0.0006
386 DERMATITIS ATOPIC 30 0.0006
387 SHOCK 13 0.0006
388 ABDOMINAL PAIN UPPER 116 0.0006
389 COMPRESSION FRACTURE 3 0.0006
390 INJECTION SITE DISCHARGE 3 0.0006
391 TOXICITY TO VARIOUS AGENTS 94 0.0006
392 CARDIAC ARREST 46 0.0006
393 ANAL ABSCESS 3 0.0006
394 GINGIVITIS 3 0.0006
395 ERYTHEMA OF EYELID 3 0.0006
396 VISUAL FIELD DEFECT 4 0.0006
397 DEVICE LEAKAGE 24 0.0006
398 HYPERHIDROSIS 71 0.0006
399 ASPIRATION 6 0.0005
400 MAJOR DEPRESSION 4 0.0005
401 SURGERY 32 0.0005
402 HIATUS HERNIA 7 0.0005
403 RENAL INJURY 16 0.0005
404 BLOOD UREA INCREASED 9 0.0005
405 INTENTIONAL PRODUCT MISUSE 47 0.0005
406 PRODUCT USE IN UNAPPROVED INDICATION 133 0.0005
407 MUCOSAL INFLAMMATION 14 0.0005
408 GASTROOESOPHAGEAL REFLUX DISEASE 43 0.0005
409 GASTRITIS 14 0.0005
410 METABOLIC ACIDOSIS 17 0.0005
411 INTESTINAL OBSTRUCTION 20 0.0005
412 BLOOD SODIUM DECREASED 10 0.0005
413 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
414 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
415 FLATULENCE 30 0.0005
416 DRUG ABUSE 44 0.0005
417 SPUTUM DISCOLOURED 5 0.0005
418 DERMATITIS CONTACT 6 0.0005
419 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
420 DISSOCIATION 4 0.0005
421 HALLUCINATION, VISUAL 11 0.0005
422 COUGH 146 0.0005
423 RENAL FAILURE CHRONIC 4 0.0005
424 INFLUENZA 58 0.0005
425 HYPOKALAEMIA 24 0.0005
426 RENAL FAILURE 69 0.0005
427 ELECTROLYTE IMBALANCE 6 0.0005
428 HYPOVOLAEMIA 3 0.0005
429 VITAMIN D DEFICIENCY 5 0.0005
430 BRAIN FOG 8 0.0005
431 RENAL TUBULAR NECROSIS 5 0.0005
432 DECREASED INTEREST 3 0.0005
433 VOMITING 239 0.0005
434 ASPARTATE AMINOTRANSFERASE INCREASED 27 0.0005
435 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
436 HOSPICE CARE 5 0.0005
437 DRUG SCREEN POSITIVE 4 0.0005
438 ILLNESS 52 0.0005
439 DISORIENTATION 20 0.0005
440 ASTHMA 57 0.0005
441 ISCHAEMIC STROKE 9 0.0005
442 GASTROINTESTINAL DISORDER 45 0.0005
443 ATRIAL FLUTTER 4 0.0005
444 TREMOR 83 0.0005
445 OXYGEN SATURATION DECREASED 28 0.0005
446 LEUKOCYTOSIS 9 0.0005
447 LACRIMATION INCREASED 15 0.0005
448 PRODUCT ADMINISTRATION ERROR 10 0.0005
449 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 9 0.0005
450 INTENTIONAL DOSE OMISSION 14 0.0005
451 MOTOR DYSFUNCTION 5 0.0005
452 PYREXIA 169 0.0005
453 NEUTROPHIL COUNT INCREASED 5 0.0005
454 DEPRESSION 111 0.0005
455 HYPERAESTHESIA 4 0.0005
456 POOR VENOUS ACCESS 5 0.0005
457 MENSTRUAL DISORDER 4 0.0005
458 SEPTIC SHOCK 21 0.0005
459 MENTAL DISORDER 21 0.0005
460 PHOTOPHOBIA 9 0.0005
461 DYSPEPSIA 47 0.0005
462 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
463 SYNCOPE 47 0.0005
464 PRODUCT DOSE OMISSION ISSUE 138 0.0005
465 INCOHERENT 3 0.0005
466 DRUG SPECIFIC ANTIBODY PRESENT 3 0.0005
467 BIPOLAR DISORDER 5 0.0005
468 KIDNEY INFECTION 9 0.0005
469 TREATMENT NONCOMPLIANCE 25 0.0005
470 TOOTH INFECTION 6 0.0005
471 CORONAVIRUS INFECTION 3 0.0005
472 IMMUNOSUPPRESSION 4 0.0005
473 ANAPHYLACTIC REACTION 25 0.0005
474 DYSPNOEA EXERTIONAL 17 0.0005
475 CONSTIPATION 98 0.0004
476 ENCEPHALOPATHY 11 0.0004
477 QUALITY OF LIFE DECREASED 6 0.0004
478 ORAL PAIN 10 0.0004
479 BLOOD CALCIUM DECREASED 5 0.0004
480 CHROMATURIA 10 0.0004
481 PRODUCTIVE COUGH 21 0.0004
482 HIDRADENITIS 4 0.0004
483 EXOSTOSIS 4 0.0004
484 RIB FRACTURE 9 0.0004
485 BRAIN NEOPLASM 4 0.0004
486 NEOPLASM 5 0.0004
487 RESPIRATORY DISTRESS 12 0.0004
488 TOOTH LOSS 9 0.0004
489 HAIR GROWTH ABNORMAL 3 0.0004
490 BLOOD POTASSIUM DECREASED 13 0.0004
491 VISION BLURRED 59 0.0004
492 MASS 6 0.0004
493 LUNG DISORDER 21 0.0004
494 INSOMNIA 114 0.0004
495 PALPITATIONS 50 0.0004
496 SQUAMOUS CELL CARCINOMA 4 0.0004
497 EATING DISORDER 9 0.0004
498 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
499 DRUG DOSE OMISSION BY DEVICE 33 0.0004
500 BLOOD URINE PRESENT 8 0.0004
501 IRRITABLE BOWEL SYNDROME 9 0.0004
502 ACCIDENT 5 0.0004
503 HYPERLIPIDAEMIA 5 0.0004
504 PERICARDITIS 7 0.0004
505 DRUG PRESCRIBING ERROR 8 0.0004
506 DIABETIC KETOACIDOSIS 10 0.0004
507 SINUS BRADYCARDIA 4 0.0004
508 PRODUCT PRESCRIBING ISSUE 9 0.0004
509 NASOPHARYNGITIS 76 0.0004
510 ADRENAL INSUFFICIENCY 5 0.0004
511 CONDITION AGGRAVATED 125 0.0004
512 DISCOMFORT 25 0.0004
513 OFF LABEL USE 358 0.0004
514 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
515 FEBRILE NEUTROPENIA 27 0.0004
516 SMALL INTESTINAL OBSTRUCTION 5 0.0004
517 CEREBRAL DISORDER 3 0.0004
518 URINARY INCONTINENCE 12 0.0004
519 HAEMATOCRIT DECREASED 8 0.0004
520 PHARYNGITIS 5 0.0004
521 RESPIRATORY DISORDER 12 0.0004
522 SECRETION DISCHARGE 5 0.0004
523 PRODUCT PHYSICAL ISSUE 8 0.0004
524 BRAIN OEDEMA 5 0.0004
525 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
526 HYPOTHERMIA 4 0.0004
527 STAPHYLOCOCCAL INFECTION 13 0.0004
528 EYELID PTOSIS 4 0.0004
529 INFUSION RELATED REACTION 26 0.0004
530 DIARRHOEA 253 0.0004
531 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
532 DYSPHAGIA 37 0.0004
533 FOOD ALLERGY 3 0.0004
534 WHEEZING 23 0.0004
535 INFLAMMATION 20 0.0004
536 CONCUSSION 3 0.0004
537 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
538 OSTEOMYELITIS 7 0.0004
539 HYPERBILIRUBINAEMIA 4 0.0004
540 RED BLOOD CELL COUNT DECREASED 11 0.0004
541 ANGER 13 0.0004
542 PRODUCT USE ISSUE 72 0.0004
543 GASTROINTESTINAL INFLAMMATION 3 0.0004
544 PRODUCT DOSE OMISSION 25 0.0004
545 HYPERTENSION 81 0.0004
546 TRANSFUSION 4 0.0004
547 ORAL CANDIDIASIS 5 0.0004
548 SCRATCH 4 0.0004
549 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
550 DEPRESSED MOOD 20 0.0004
551 FULL BLOOD COUNT ABNORMAL 4 0.0004
552 BLOOD ALBUMIN DECREASED 3 0.0004
553 HALLUCINATION, AUDITORY 6 0.0004
554 COVID-19 66 0.0004
555 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
556 LIVER FUNCTION TEST INCREASED 8 0.0004
557 EMOTIONAL DISTRESS 45 0.0004
558 NEURALGIA 9 0.0004
559 BLOOD POTASSIUM INCREASED 6 0.0004
560 FOOT FRACTURE 7 0.0004
561 DECUBITUS ULCER 3 0.0004
562 DEVICE ISSUE 33 0.0004
563 PALLOR 10 0.0004
564 PULMONARY THROMBOSIS 4 0.0004
565 ABNORMAL FAECES 3 0.0004
566 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
567 MULTIPLE FRACTURES 6 0.0004
568 ESCHERICHIA INFECTION 3 0.0004
569 POST PROCEDURAL COMPLICATION 7 0.0004
570 URINARY TRACT INFECTION 62 0.0004
571 VENTRICULAR FIBRILLATION 4 0.0004
572 HYPOMAGNESAEMIA 5 0.0004
573 ROAD TRAFFIC ACCIDENT 15 0.0004
574 RASH PAPULAR 8 0.0004
575 SKIN INFECTION 4 0.0004
576 NEPHROPATHY TOXIC 4 0.0004
577 CANDIDA INFECTION 6 0.0004
578 PRODUCT AVAILABILITY ISSUE 8 0.0004
579 PRESCRIBED UNDERDOSE 7 0.0004
580 SCAB 4 0.0004
581 DRUG-INDUCED LIVER INJURY 11 0.0004
582 HYPOTENSION 70 0.0003
583 BLOOD MAGNESIUM DECREASED 3 0.0003
584 HYSTERECTOMY 3 0.0003
585 OROPHARYNGEAL PAIN 32 0.0003
586 DEVICE BREAKAGE 14 0.0003
587 ABDOMINAL DISTENSION 36 0.0003
588 MADAROSIS 4 0.0003
589 SEXUAL DYSFUNCTION 4 0.0003
590 CARDIOMYOPATHY 5 0.0003
591 SOMNOLENCE 68 0.0003
592 BLOOD CREATININE INCREASED 22 0.0003
593 PULMONARY HYPERTENSION 7 0.0003
594 POLLAKIURIA 14 0.0003
595 HAEMOLYTIC ANAEMIA 3 0.0003
596 FEELING ABNORMAL 80 0.0003
597 WRIST FRACTURE 4 0.0003
598 DEVELOPMENTAL DELAY 3 0.0003
599 SEPSIS 37 0.0003
600 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
601 LOCALISED INFECTION 8 0.0003
602 CORONARY ARTERY DISEASE 10 0.0003
603 NOCTURIA 4 0.0003
604 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
605 SKIN LESION 9 0.0003
606 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
607 ECZEMA 17 0.0003
608 TENDON RUPTURE 4 0.0003
609 HYPERCALCAEMIA 4 0.0003
610 FEELING COLD 9 0.0003
611 MUSCULOSKELETAL CHEST PAIN 5 0.0003
612 WOUND 9 0.0003
613 EJECTION FRACTION DECREASED 5 0.0003
614 WEIGHT INCREASED 72 0.0003
615 PRODUCT DISPENSING ERROR 7 0.0003
616 MYOCARDIAL INFARCTION 56 0.0003
617 DIARRHOEA HAEMORRHAGIC 3 0.0003
618 HEADACHE 201 0.0003
619 THERAPY PARTIAL RESPONDER 5 0.0003
620 DYSARTHRIA 12 0.0003
621 DERMATITIS ALLERGIC 4 0.0003
622 PAIN IN JAW 9 0.0003
623 PRODUCT USE COMPLAINT 5 0.0003
624 SICKLE CELL ANAEMIA WITH CRISIS 5 0.0003
625 OCULAR HYPERAEMIA 15 0.0003
626 HEAD INJURY 10 0.0003
627 TOOTH DISORDER 7 0.0003
628 RESPIRATORY TRACT CONGESTION 5 0.0003
629 EYE INFLAMMATION 3 0.0003
630 RASH 137 0.0003
631 AFFECT LABILITY 3 0.0003
632 HIP FRACTURE 10 0.0003
633 PRESCRIBED OVERDOSE 6 0.0003
634 ABDOMINAL DISCOMFORT 52 0.0003
635 HEART RATE IRREGULAR 7 0.0003
636 MUSCLE TIGHTNESS 5 0.0003
637 EAR PAIN 6 0.0003
638 HAEMORRHOIDS 6 0.0003
639 SUICIDAL IDEATION 28 0.0003
640 NEPHROLITHIASIS 14 0.0003
641 MUSCLE SPASMS 56 0.0003
642 SKIN DISCOLOURATION 14 0.0003
643 NECK PAIN 17 0.0003
644 MUSCLE TWITCHING 7 0.0003
645 SARS-COV-2 TEST POSITIVE 4 0.0003
646 BLOOD PRESSURE ABNORMAL 6 0.0003
647 HYPOTONIA 3 0.0003
648 COAGULOPATHY 5 0.0003
649 PRURITUS 115 0.0003
650 GAIT INABILITY 10 0.0003
651 BRAIN INJURY 3 0.0003
652 CYTOKINE RELEASE SYNDROME 6 0.0003
653 HAIR TEXTURE ABNORMAL 4 0.0003
654 NAUSEA 236 0.0003
655 FATIGUE 232 0.0003
656 FULL BLOOD COUNT DECREASED 6 0.0003
657 EMPHYSEMA 3 0.0003
658 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
659 PRODUCT TASTE ABNORMAL 4 0.0003
660 DYSKINESIA 12 0.0003
661 LIMB INJURY 8 0.0003
662 HEPATIC ENZYME INCREASED 20 0.0003
663 EUPHORIC MOOD 3 0.0003
664 ACUTE HEPATIC FAILURE 4 0.0003
665 DYSPHONIA 17 0.0003
666 HYPOGLYCAEMIA 14 0.0003
667 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 52 0.0003
668 DEVICE USE ERROR 10 0.0003
669 HUNGER 4 0.0003
670 ORTHOSTATIC HYPOTENSION 5 0.0003
671 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
672 DERMATITIS 6 0.0003
673 SYRINGE ISSUE 5 0.0003
674 CARPAL TUNNEL SYNDROME 4 0.0003
675 DRUG WITHDRAWAL SYNDROME 25 0.0003
676 HYPONATRAEMIA 16 0.0003
677 SKIN REACTION 4 0.0003
678 DIZZINESS 141 0.0003
679 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
680 JOINT INJURY 6 0.0003
681 ILL-DEFINED DISORDER 17 0.0003
682 SKIN CANCER 6 0.0003
683 CONFUSIONAL STATE 45 0.0003
684 NEEDLE ISSUE 8 0.0003
685 BONE DISORDER 5 0.0003
686 OSTEONECROSIS 9 0.0003
687 DRUG DEPENDENCE 44 0.0003
688 HAEMOGLOBIN DECREASED 28 0.0003
689 ASCITES 8 0.0003
690 GAIT DISTURBANCE 52 0.0003
691 ANGIOEDEMA 12 0.0003
692 CONTUSION 26 0.0003
693 NEUTROPHIL COUNT DECREASED 11 0.0003
694 SKIN HAEMORRHAGE 4 0.0003
695 TRANSAMINASES INCREASED 6 0.0003
696 PULMONARY MASS 4 0.0003
697 HEPATIC STEATOSIS 5 0.0003
698 COLON CANCER 4 0.0003
699 EYE PRURITUS 9 0.0003
700 SPEECH DISORDER 14 0.0003
701 LOSS OF CONSCIOUSNESS 34 0.0003
702 COLITIS 10 0.0003
703 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
704 PLEURAL EFFUSION 16 0.0003
705 HEART RATE INCREASED 26 0.0003
706 LOWER LIMB FRACTURE 5 0.0003
707 DEVICE RELATED INFECTION 4 0.0003
708 GLAUCOMA 5 0.0003
709 PERICARDIAL EFFUSION 6 0.0003
710 BLOOD BILIRUBIN INCREASED 7 0.0003
711 ANKLE FRACTURE 4 0.0003
712 FALL 86 0.0003
713 WHITE BLOOD CELL COUNT DECREASED 28 0.0003
714 RASH MACULAR 9 0.0003
715 CARDIAC DISORDER 24 0.0003
716 CHOKING 5 0.0003
717 ORAL HERPES 5 0.0003
718 BONE PAIN 15 0.0003
719 BLOOD PRESSURE DECREASED 17 0.0003
720 SKIN FISSURES 5 0.0003
721 FLUSHING 26 0.0003
722 DISABILITY 5 0.0003
723 UPPER LIMB FRACTURE 5 0.0003
724 PANCYTOPENIA 14 0.0003
725 PAIN 153 0.0002
726 SKIN EXFOLIATION 21 0.0002
727 NERVOUSNESS 13 0.0002
728 HEPATITIS C 3 0.0002
729 INJECTION SITE SWELLING 19 0.0002
730 HYPERSENSITIVITY 46 0.0002
731 PRESYNCOPE 6 0.0002
732 TASTE DISORDER 5 0.0002
733 MALAISE 108 0.0002
734 COLITIS ULCERATIVE 11 0.0002
735 BACK DISORDER 4 0.0002
736 PANCREATITIS 13 0.0002
737 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
738 MANIA 4 0.0002
739 CHEST PAIN 45 0.0002
740 GENERALISED OEDEMA 3 0.0002
741 VENTRICULAR TACHYCARDIA 4 0.0002
742 PHOTOSENSITIVITY REACTION 4 0.0002
743 DRUG LEVEL INCREASED 4 0.0002
744 ARTHRITIS 19 0.0002
745 ILEUS 3 0.0002
746 EXPOSURE DURING PREGNANCY 15 0.0002
747 HAIR COLOUR CHANGES 3 0.0002
748 PAIN IN EXTREMITY 71 0.0002
749 DYSSTASIA 7 0.0002
750 OEDEMA 13 0.0002
751 ACUTE MYOCARDIAL INFARCTION 7 0.0002
752 MOUTH ULCERATION 5 0.0002
753 FACE OEDEMA 4 0.0002
754 INJECTION SITE IRRITATION 3 0.0002
755 ASTHENIA 88 0.0002
756 ERECTILE DYSFUNCTION 6 0.0002
757 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
758 MUSCULOSKELETAL DISCOMFORT 4 0.0002
759 DRUG INEFFECTIVE 305 0.0002
760 PRURITUS GENERALISED 5 0.0002
761 NIGHTMARE 8 0.0002
762 DEEP VEIN THROMBOSIS 15 0.0002
763 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
764 ANAEMIA 44 0.0002
765 EYE PAIN 13 0.0002
766 SWELLING FACE 15 0.0002
767 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
768 MUSCULOSKELETAL PAIN 12 0.0002
769 EPILEPSY 7 0.0002
770 APPLICATION SITE ERYTHEMA 6 0.0002
771 DYSPNOEA 129 0.0002
772 ANKYLOSING SPONDYLITIS 3 0.0002
773 METASTASES TO LIVER 4 0.0002
774 COLD SWEAT 4 0.0002
775 LYMPHOCYTE COUNT DECREASED 4 0.0002
776 HERPES ZOSTER 13 0.0002
777 FEMUR FRACTURE 7 0.0002
778 LYMPHADENOPATHY 8 0.0002
779 HEAD DISCOMFORT 4 0.0002
780 EYE HAEMORRHAGE 3 0.0002
781 UNEVALUABLE EVENT 17 0.0002
782 THIRST 4 0.0002
783 FEAR 6 0.0002
784 DIABETES MELLITUS 17 0.0002
785 DISTURBANCE IN ATTENTION 12 0.0002
786 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 45 0.0002
787 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
788 BALANCE DISORDER 19 0.0002
789 HYPERGLYCAEMIA 8 0.0002
790 RESPIRATORY ARREST 6 0.0002
791 DRUG INTOLERANCE 21 0.0002
792 ABNORMAL DREAMS 6 0.0002
793 TREATMENT FAILURE 18 0.0002
794 ARTHROPATHY 12 0.0002
795 ATRIAL FIBRILLATION 21 0.0002
796 INJECTION SITE PAIN 66 0.0002
797 EYE SWELLING 8 0.0002
798 THINKING ABNORMAL 4 0.0002
799 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 10 0.0002
800 BURNING SENSATION 15 0.0002
801 SWELLING 20 0.0002
802 BLOOD TEST ABNORMAL 3 0.0002
803 DEVICE OCCLUSION 3 0.0002
804 OSTEOARTHRITIS 9 0.0002
805 DIALYSIS 3 0.0002
806 ARRHYTHMIA 10 0.0002
807 SKIN DISORDER 7 0.0002
808 URINARY RETENTION 7 0.0002
809 OVERDOSE 45 0.0002
810 HYPERTHYROIDISM 3 0.0002
811 INFLUENZA LIKE ILLNESS 17 0.0002
812 GASTROENTERITIS 3 0.0002
813 UNDERDOSE 15 0.0002
814 CHILLS 24 0.0002
815 INJECTION SITE URTICARIA 5 0.0002
816 LABORATORY TEST ABNORMAL 6 0.0002
817 LIVER DISORDER 9 0.0002
818 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
819 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
820 INJECTION SITE ERYTHEMA 25 0.0002
821 IMMUNODEFICIENCY 3 0.0002
822 PERIPHERAL SWELLING 31 0.0002
823 BONE LOSS 3 0.0002
824 HEPATIC FAILURE 6 0.0002
825 CELLULITIS 10 0.0002
826 BACK PAIN 46 0.0002
827 BLOOD COUNT ABNORMAL 3 0.0002
828 DEVICE FAILURE 3 0.0002
829 PLATELET COUNT DECREASED 21 0.0002
830 BONE MARROW FAILURE 4 0.0002
831 THERAPY INTERRUPTED 14 0.0002
832 INJECTION SITE RASH 6 0.0002
833 MOBILITY DECREASED 14 0.0002
834 THERAPY CESSATION 10 0.0002
835 SKIN ULCER 5 0.0002
836 RENAL DISORDER 9 0.0002
837 DELUSION 3 0.0002
838 HAEMATOMA 5 0.0002
839 COGNITIVE DISORDER 9 0.0002
840 BASAL CELL CARCINOMA 3 0.0002
841 PANIC ATTACK 7 0.0002
842 HAEMORRHAGE 20 0.0002
843 RENAL IMPAIRMENT 16 0.0002
844 DYSURIA 7 0.0002
845 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
846 MYALGIA 32 0.0002
847 EPISTAXIS 14 0.0002
848 CARDIAC FAILURE CONGESTIVE 15 0.0002
849 THROMBOSIS 15 0.0002
850 RECTAL HAEMORRHAGE 8 0.0002
851 POOR QUALITY SLEEP 4 0.0002
852 CHEST DISCOMFORT 19 0.0002
853 FREQUENT BOWEL MOVEMENTS 5 0.0002
854 INJURY 13 0.0002
855 THROAT TIGHTNESS 5 0.0002
856 BLOOD PRESSURE INCREASED 28 0.0002
857 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
858 DRUG DOSE OMISSION 30 0.0002
859 THERAPEUTIC RESPONSE DECREASED 11 0.0002
860 HAEMATOCHEZIA 10 0.0002
861 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
862 RASH MACULO-PAPULAR 4 0.0002
863 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
864 FEELING HOT 11 0.0002
865 PULMONARY EMBOLISM 17 0.0002
866 GLOSSODYNIA 4 0.0002
867 BLISTER 10 0.0002
868 NEUTROPENIA 24 0.0002
869 CIRCULATORY COLLAPSE 3 0.0002
870 INJECTION SITE BRUISING 14 0.0002
871 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
872 HAEMATURIA 6 0.0002
873 ADVERSE EVENT 16 0.0002
874 DEVICE DEFECTIVE 3 0.0002
875 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
876 DEVICE USE ISSUE 3 0.0002
877 HYPERKALAEMIA 6 0.0002
878 ARTHRALGIA 71 0.0002
879 DRUG ERUPTION 3 0.0002
880 AMNESIA 11 0.0002
881 PRODUCT PRESCRIBING ERROR 4 0.0002
882 GOUT 3 0.0002
883 MUSCULAR WEAKNESS 19 0.0002
884 HYPOAESTHESIA 25 0.0002
885 BLOOD PRESSURE FLUCTUATION 4 0.0002
886 APHASIA 5 0.0002
887 DRUG EFFECT INCOMPLETE 6 0.0002
888 ACCIDENTAL OVERDOSE 6 0.0002
889 INJECTION SITE MASS 6 0.0002
890 DEVICE DISLOCATION 7 0.0002
891 AGEUSIA 4 0.0002
892 NERVOUS SYSTEM DISORDER 5 0.0002
893 HEPATIC CIRRHOSIS 3 0.0002
894 FRACTURE 3 0.0002
895 ACNE 12 0.0002
896 PRODUCT COMPLAINT 4 0.0002
897 HAEMATEMESIS 4 0.0002
898 CARDIOVASCULAR DISORDER 4 0.0002
899 FEELING JITTERY 3 0.0002
900 CONVULSION 9 0.0002
901 DEVICE MALFUNCTION 11 0.0002
902 MOVEMENT DISORDER 5 0.0002
903 DRUG RESISTANCE 4 0.0002
904 NIGHT SWEATS 5 0.0002
905 HERNIA 3 0.0002
906 ERUCTATION 3 0.0002
907 NO ADVERSE EVENT 28 0.0002
908 EXPOSURE VIA SKIN CONTACT 4 0.0002
909 DIPLOPIA 4 0.0002
910 INCORRECT DOSE ADMINISTERED 35 0.0002
911 DEAFNESS 4 0.0002
912 MEMORY IMPAIRMENT 21 0.0002
913 ALOPECIA 30 0.0002
914 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
915 EYE DISORDER 5 0.0002
916 THROMBOCYTOPENIA 17 0.0002
917 EXPIRED PRODUCT ADMINISTERED 5 0.0002
918 DRY SKIN 20 0.0001
919 CARDIAC FAILURE 12 0.0001
920 MENSTRUATION IRREGULAR 4 0.0001
921 INJECTION SITE PRURITUS 10 0.0001
922 PAIN OF SKIN 4 0.0001
923 TYPE 2 DIABETES MELLITUS 5 0.0001
924 DISEASE RECURRENCE 7 0.0001
925 DEATH 124 0.0001
926 NEOPLASM PROGRESSION 5 0.0001
927 DISEASE PROGRESSION 17 0.0001
928 DEMENTIA 4 0.0001
929 IMPAIRED WORK ABILITY 3 0.0001
930 DRY EYE 7 0.0001
931 ANGINA PECTORIS 4 0.0001
932 OEDEMA PERIPHERAL 17 0.0001
933 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
934 INJECTION SITE HAEMORRHAGE 11 0.0001
935 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
936 VISUAL IMPAIRMENT 17 0.0001
937 NEUROPATHY PERIPHERAL 13 0.0001
938 PSYCHOTIC DISORDER 4 0.0001
939 HEPATOTOXICITY 3 0.0001
940 PULMONARY OEDEMA 6 0.0001
941 ADVERSE DRUG REACTION 12 0.0001
942 PARAESTHESIA 21 0.0001
943 HOT FLUSH 10 0.0001
944 COMPLETED SUICIDE 11 0.0001
945 BRADYCARDIA 7 0.0001
946 ERYTHEMA 27 0.0001
947 SKIN IRRITATION 6 0.0001
948 INJECTION SITE REACTION 9 0.0001
949 RASH PRURITIC 7 0.0001
950 SWOLLEN TONGUE 4 0.0001
951 COMA 6 0.0001
952 MEDICATION ERROR 7 0.0001
953 MUSCULOSKELETAL STIFFNESS 11 0.0001
954 CHOLELITHIASIS 4 0.0001
955 IMPAIRED HEALING 4 0.0001
956 CARDIO-RESPIRATORY ARREST 5 0.0001
957 GASTRIC DISORDER 4 0.0001
958 HEART RATE DECREASED 4 0.0001
959 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
960 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
961 PRODUCT ADHESION ISSUE 4 0.0001
962 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
963 DRUG EFFECT DECREASED 6 0.0001
964 PRODUCT QUALITY ISSUE 15 0.0001
965 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
966 BLOOD CHOLESTEROL INCREASED 5 0.0001
967 PSORIASIS 14 0.0001
968 HEPATIC FUNCTION ABNORMAL 4 0.0001
969 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
970 MULTIPLE SCLEROSIS 5 0.0001
971 PRODUCT SUBSTITUTION ISSUE 6 0.0001
972 LEUKOPENIA 5 0.0001
973 SKIN BURNING SENSATION 7 0.0001
974 RHEUMATOID ARTHRITIS 11 0.0001
975 DYSGEUSIA 7 0.0001
976 HYPOTHYROIDISM 3 0.0001
977 THROAT IRRITATION 4 0.0001
978 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
979 BLOOD GLUCOSE INCREASED 16 0.0001
980 CEREBRAL HAEMORRHAGE 3 0.0001
981 BLOOD GLUCOSE DECREASED 4 0.0001
982 CEREBROVASCULAR ACCIDENT 14 0.0001
983 PRODUCT STORAGE ERROR 7 0.0001
984 DEVICE DIFFICULT TO USE 5 0.0001
985 NEOPLASM MALIGNANT 5 0.0001
986 EXTRA DOSE ADMINISTERED 3 0.0001
987 DRY MOUTH 6 0.0001
988 VERTIGO 4 0.0001
989 JOINT SWELLING 7 0.0001
990 CATARACT 3 0.0001
991 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000